• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension.毛细血管后和毛细血管前合并性肺动脉高压中血管重塑的血流动力学证据。
Pulm Circ. 2016 Sep;6(3):313-21. doi: 10.1086/688516.
2
A simple echocardiographic score for the diagnosis of pulmonary vascular disease in heart failure.一种用于诊断心力衰竭中肺血管疾病的简单超声心动图评分。
J Cardiovasc Med (Hagerstown). 2017 Apr;18(4):237-243. doi: 10.2459/JCM.0000000000000485.
3
Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.对毛细血管后和毛细血管前合并性肺动脉高压的临床与生物学见解。
J Am Coll Cardiol. 2016 Dec 13;68(23):2525-2536. doi: 10.1016/j.jacc.2016.09.942.
4
Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre- and postcapillary pulmonary hypertension.临床特征无法识别从单纯性毛细血管后肺动脉高压进展为毛细血管前和毛细血管后肺动脉高压的风险。
Pulm Circ. 2023 Jun 15;13(2):e12249. doi: 10.1002/pul2.12249. eCollection 2023 Apr.
5
Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.左心衰竭中肺动脉高压的血流动力学表型分析
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.117.004082.
6
Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study.肺动脉高压合并慢性肾脏病患者吸入一氧化氮后的血流动力学反应:一项回顾性队列研究。
Pulm Circ. 2024 Feb 10;14(1):e12341. doi: 10.1002/pul2.12341. eCollection 2024 Jan.
7
Can Inhaled Nitric Oxide Response Predict Tolerance to Therapies and Survival in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension?吸入一氧化氮反应能否预测毛细血管前和毛细血管后肺动脉高压患者对治疗的耐受性和生存?
Am J Cardiol. 2023 Nov 15;207:363-369. doi: 10.1016/j.amjcard.2023.09.032. Epub 2023 Sep 30.
8
Arterial load and right ventricular-vascular coupling in pulmonary hypertension.肺动脉高压中的动脉负荷和右心室-血管耦联。
J Appl Physiol (1985). 2021 Jul 1;131(1):424-433. doi: 10.1152/japplphysiol.00204.2021. Epub 2021 May 27.
9
Clinical significance of pulmonary hypertension in patients with constrictive pericarditis.缩窄性心包炎患者肺动脉高压的临床意义。
Heart. 2021 Oct;107(20):1651-1656. doi: 10.1136/heartjnl-2021-319149. Epub 2021 Jul 20.
10
Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension.针对肺动脉高压患者进行液体负荷试验的临床意义
Chest. 2017 Jan;151(1):119-126. doi: 10.1016/j.chest.2016.08.1439. Epub 2016 Aug 26.

引用本文的文献

1
Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre- and postcapillary pulmonary hypertension.临床特征无法识别从单纯性毛细血管后肺动脉高压进展为毛细血管前和毛细血管后肺动脉高压的风险。
Pulm Circ. 2023 Jun 15;13(2):e12249. doi: 10.1002/pul2.12249. eCollection 2023 Apr.
2
Pathogenesis of pulmonary hypertension caused by left heart disease.左心疾病所致肺动脉高压的发病机制。
Front Cardiovasc Med. 2023 Mar 3;10:1079142. doi: 10.3389/fcvm.2023.1079142. eCollection 2023.
3
Parameter inference in a computational model of haemodynamics in pulmonary hypertension.肺动脉高压血液动力学计算模型中的参数推断。
J R Soc Interface. 2023 Mar;20(200):20220735. doi: 10.1098/rsif.2022.0735. Epub 2023 Mar 1.
4
Pulmonary Hypertension in Heart Failure.心力衰竭中的肺动脉高压
Int J Heart Fail. 2021 Apr 21;3(3):147-159. doi: 10.36628/ijhf.2020.0053. eCollection 2021 Jul.
5
Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.阐述射血分数保留的心力衰竭中肺动脉高压的临床意义和病理生理学:行动呼吁:美国心脏协会的科学声明。
Circulation. 2022 Aug 16;146(7):e73-e88. doi: 10.1161/CIR.0000000000001079. Epub 2022 Jul 11.
6
Pulmonary vascular distensibility with passive leg raise is comparable to exercise and predictive of clinical outcomes in pulmonary hypertension.被动抬腿试验时的肺血管扩张性与运动时相当,且可预测肺动脉高压的临床结局。
Pulm Circ. 2022 Jan 12;12(1):e12029. doi: 10.1002/pul2.12029. eCollection 2022 Jan.
7
Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.理解左心疾病所致肺动脉高压的病理生理学。
Circ Res. 2022 Apr 29;130(9):1382-1403. doi: 10.1161/CIRCRESAHA.122.319967. Epub 2022 Apr 28.
8
Current Understanding of Circulating Biomarkers in Pulmonary Hypertension Due to Left Heart Disease.目前对左心疾病所致肺动脉高压中循环生物标志物的认识。
Front Med (Lausanne). 2020 Oct 7;7:570016. doi: 10.3389/fmed.2020.570016. eCollection 2020.
9
Pulmonary Hypertension in Heart Failure Patients.心力衰竭患者的肺动脉高压
Card Fail Rev. 2020 Apr 9;6:e05. doi: 10.15420/cfr.2019.09. eCollection 2020 Mar.
10
Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension.转录组分析将 ID2 的表达与毛细血管前和毛细血管后肺动脉高压相关联。
Sci Rep. 2019 Dec 20;9(1):19572. doi: 10.1038/s41598-019-55700-y.

本文引用的文献

1
Integration of complex data sources to provide biologic insight into pulmonary vascular disease (2015 Grover Conference Series).整合复杂数据源以深入了解肺血管疾病(2015年格罗弗会议系列)
Pulm Circ. 2016 Sep;6(3):251-60. doi: 10.1086/686995.
2
Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.大型患者队列中边缘性肺动脉高压与死亡率和住院率的关联:来自退伍军人事务部临床评估、报告和跟踪项目的见解
Circulation. 2016 Mar 29;133(13):1240-8. doi: 10.1161/CIRCULATIONAHA.115.020207. Epub 2016 Feb 12.
3
Pulmonary vascular resistance and compliance relationship in pulmonary hypertension.肺动脉高压中的肺血管阻力和顺应性关系。
Eur Respir J. 2015 Oct;46(4):1178-89. doi: 10.1183/13993003.00741-2015. Epub 2015 Sep 4.
4
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015 ESC/ERS 肺动脉高压诊断与治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断与治疗工作组制定:该指南得到了欧洲儿科和先天性心脏病协会(AEPC)以及国际心肺移植学会(ISHLT)的认可。
Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29.
5
Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.心力衰竭相关肺动脉高压。流行病学、右心室功能与生存。
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1234-46. doi: 10.1164/rccm.201503-0529OC.
6
Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction.肺动脉容量是射血分数保留的心力衰竭患者死亡率的重要预测指标。
JACC Heart Fail. 2015 Jun;3(6):467-474. doi: 10.1016/j.jchf.2015.01.013.
7
Measurement to predict survival: the case of diastolic pulmonary gradient.预测生存的测量指标:以舒张期肺梯度为例。
JACC Heart Fail. 2015 May;3(5):425. doi: 10.1016/j.jchf.2014.12.014.
8
The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease.肺循环的阻力-顺应性乘积在健康状态和肺血管疾病中有所不同。
Physiol Rep. 2015 Apr;3(4). doi: 10.14814/phy2.12363.
9
Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension.心力衰竭合并反应性肺动脉高压患者的肺动脉顺应性。
Eur J Heart Fail. 2015 Jan;17(1):74-80. doi: 10.1002/ejhf.192. Epub 2014 Nov 11.
10
Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure.心力衰竭患者与非心力衰竭患者运动与容量扩张的血液动力学差异效应。
Circ Heart Fail. 2015 Jan;8(1):41-8. doi: 10.1161/CIRCHEARTFAILURE.114.001731. Epub 2014 Oct 23.

毛细血管后和毛细血管前合并性肺动脉高压中血管重塑的血流动力学证据。

Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension.

作者信息

Assad Tufik R, Brittain Evan L, Wells Quinn S, Farber-Eger Eric H, Halliday Stephen J, Doss Laura N, Xu Meng, Wang Li, Harrell Frank E, Yu Chang, Robbins Ivan M, Newman John H, Hemnes Anna R

机构信息

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

出版信息

Pulm Circ. 2016 Sep;6(3):313-21. doi: 10.1086/688516.

DOI:10.1086/688516
PMID:27683608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5019084/
Abstract

Although commonly encountered, patients with combined postcapillary and precapillary pulmonary hypertension (Cpc-PH) have poorly understood pulmonary vascular properties. The product of pulmonary vascular resistance and compliance, resistance-compliance (RC) time, is a measure of pulmonary vascular physiology. While RC time is lower in postcapillary PH than in precapillary PH, the RC time in Cpc-PH and the effect of pulmonary wedge pressure (PWP) on RC time are unknown. We tested the hypothesis that Cpc-PH has an RC time that resembles that in pulmonary arterial hypertension (PAH) more than that in isolated postcapillary PH (Ipc-PH). We analyzed the hemodynamics of 282 consecutive patients with PH referred for right heart catheterization (RHC) with a fluid challenge from 2004 to 2013 (cohort A) and 4,382 patients who underwent RHC between 1998 and 2014 for validation (cohort B). Baseline RC time in Cpc-PH was higher than that in Ipc-PH and lower than that in PAH in both cohorts (P < 0.001). In cohort A, RC time decreased after fluid challenge in patients with Ipc-PH but not in those with PAH or Cpc-PH (P < 0.001). In cohort B, the inverse relationship of pulmonary vascular compliance and resistance, as well as that of RC time and PWP, in Cpc-PH was similar to that in PAH and distinct from that in Ipc-PH. Our findings demonstrate that patients with Cpc-PH have pulmonary vascular physiology that resembles that of patients with PAH more than that of Ipc-PH patients. Further study is warranted to identify determinants of vascular remodeling and assess therapeutic response in this subset of PH.

摘要

尽管毛细血管后和毛细血管前合并性肺动脉高压(Cpc-PH)患者很常见,但人们对其肺血管特性了解甚少。肺血管阻力与顺应性的乘积,即阻力-顺应性(RC)时间,是衡量肺血管生理功能的指标。虽然毛细血管后肺动脉高压患者的RC时间低于毛细血管前肺动脉高压患者,但Cpc-PH患者的RC时间以及肺楔压(PWP)对RC时间的影响尚不清楚。我们检验了以下假设:与单纯毛细血管后肺动脉高压(Ipc-PH)患者相比,Cpc-PH患者的RC时间更类似于肺动脉高压(PAH)患者。我们分析了2004年至2013年因右心导管检查(RHC)接受液体负荷试验的282例连续PH患者的血流动力学情况(队列A),以及1998年至2014年接受RHC以进行验证的4382例患者(队列B)。在两个队列中,Cpc-PH患者的基线RC时间均高于Ipc-PH患者,低于PAH患者(P<0.001)。在队列A中,Ipc-PH患者在液体负荷试验后RC时间降低,而PAH或Cpc-PH患者则未降低(P<0.001)。在队列B中,Cpc-PH患者肺血管顺应性与阻力的反比关系以及RC时间与PWP的反比关系与PAH患者相似,与Ipc-PH患者不同。我们的研究结果表明,Cpc-PH患者的肺血管生理功能更类似于PAH患者,而不是Ipc-PH患者。有必要进一步研究以确定血管重塑的决定因素,并评估这一PH亚组的治疗反应。